In the general population, individuals with nonfasting triglyceride level of 6.6 mmol/L have increased risk for myocardial infarction, ischemic heart disease, ischemic stroke, and all-cause mortality compared with individuals with a level of 0.8 mmol/L.
The REDUCE-IT study identified a lower risk for ischemic events among the patients with high fasting triglyceride levels who were treated with a statin and received icosapent ethyl than those who received placebo.
Triglyceride-rich lipoproteins and their remnants have been shown to be independently associated with increased lipid-related risk for CVD.
A recent study by Nordestgaard and colleagues revealed that high levels of triglyceride molecules in LDL-C are robustly linked to increased risk for atherosclerotic CVD.
Learn more about hypertriglyceridemia.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Romesh Khardori. Fast Five Quiz: Triglycerides as an Independent Cardiovascular Disease Risk Factor - Medscape - Mar 10, 2023.